A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain
Clinical trial NCT05560646 · COMPLETED
Trial details
- NCT number
- NCT05560646
- Sponsor
- Organon and Co
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-25
- Primary completion
- 2025-05-28
- Enrollment
- 354
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.